Market Overview

MNG Laboratories, Pronto Diagnostics Partner to Offer Clinical RNA Sequencing Services in Israel

Share:

MNG Laboratories, an Atlanta-based neurogenetic testing company, is
pleased to announce that it has signed a Distribution Agreement with
Pronto Diagnostics, a leading Israeli genomics company, to exclusively
market its complete line of Clinical RNA Sequencing Services in Israel.

The RNA Sequencing Services portfolio includes the MNG
Transcriptome™ complete RNA transcriptome sequencing, Gene-Specific RNA
Sequencing for the analysis of one or up to five genes for variant
investigation following a report with a VUS identified in a splice site
or intronic region and Panel-Specific RNA Sequencing which is
transcriptome analysis of a target set of genes included in a targeted
next generation sequencing panel.

"We are excited to add RNA sequencing services to our portfolio of
testing services in Israel. We chose MNG due to their experience and
leadership in rare disease diagnostics. Having the ability to offer this
important set of tests helps us to ensure we offer the best diagnostic
tools to our clients", noted Nir Navot, CEO of Pronto Diagnostics.

A recent study in Science Translational Medicine reported that RNA
sequencing was able to provide a diagnosis in 35% of patients with
muscle disorders that could not be diagnosed by DNA sequencing alone
(PMID: 28424332) and patients with other types of disorders are also
likely to benefit from this testing. Additionally, this testing can be
used to determine what effect, if any, variants of uncertain
significance (VUS) may have on transcription.

"This partnership with Pronto is an important addition to the expansion
strategy at MNG to bring our portfolio of world class neurogenetic
testing to the global rare disease diagnostic market," noted Humberto
Huerta, Senior Director of Business Development at MNG.

Under the Distribution Agreement, testing will be performed at MNG's
CLIA and CAP-accredited laboratory and a clinical report will be
delivered in as fast as 2-4 weeks.

About MNG Laboratories

MNG Laboratories is an internationally recognized clinical diagnostic
leader specializing in neurogenetic and complex biochemical testing. We
are committed to a patient-centered testing menu, high-quality
diagnostics, and first-in-class reporting driven by our Genome MaNaGer®
analysis pipeline. Our Neurogenetic Answers™ reporting process helps us
stay at the forefront of the evolving genetics field. Our team-based
approach to data interpretation ensures we provide actionable results on
the variants that cause or are likely to cause disease. Our
comprehensive approach to diagnostics is accompanied by a team of
customer support and scientific personnel available to answer your
questions regarding our process, technology, and reports. With over 16
years of neurogenetic experience, and powered by a culture of discovery
and advancement, MNG Laboratories delivers results that make a
difference for patients and their families.

More information about MNG Laboratories can be found at mnglabs.com.

About Pronto Diagnostics

Pronto Diagnostics is a leader in molecular diagnostics in Israel, since
its establishment in 1993. In its early days the company was one of the
first companies globally to develop clinical diagnostic kits for
mutation detection; over the years it has developed more than 35 CE
IVD-marked kits for the diagnosis of mutations causing a variety of
diseases. Pronto Diagnostics is distributing products and unique devices
from leading international manufacturers; it operates a molecular
clinical diagnostic laboratory, accredited by the Israeli Ministry of
Health, that is ISO 9001:2015 and ISO 27799 certified. It provides both
clinical diagnostics and clinical research services, which include DNA
purification; sequencing and deletion/duplication analysis for any gene;
fragment analysis; pharmacogenetic testing and epigenetic tests.
ProntoLab™ carries out sequencing and data analysis of whole-exome, as
well targeted gene panels for specific diseases and syndromes. Pronto
represents in Israel some of the leading international service
providers, it offers their tests in addition to its own services to
Israeli institutional customers as well as to the private diagnostic
market.

View Comments and Join the Discussion!